Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ashton

Showing results (31-40 of 169) with videos related to

Pageof 17
Sort By:
Journal of Microscopy|July 1, 1981
The myosin filament. VIII. Preservation of subfilament organizationF T Ashton, F A Pepe
European Journal of Biochemistry|April 12, 2001
The oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albuminP Finotti, A Pagetta, T Ashton
Journal of Medicinal Chemistry|March 1, 1973
Irreversible enzyme inhibitors. 197. Water-soluble reversible inhibitors of dihydrofolate reductase with potent antitumor activity derived from 4, 6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazineB R Baker, W T Ashton
Nature Chemistry|March 26, 2024
Blocking and rescuing tryptophan interactionsAidan K Haney, T Ashton Cropp
British Journal of Addiction|July 1, 1989
Alcohol taxes: do the poor pay more than the rich?T Ashton, S Casswell, L Gilmore
Journal of Medicinal Chemistry|September 1, 1974
Quinazolines as inhibitors of dihydrofolate reductase. 2J B Hynes, W T Ashton
Journal of Health Services Research & Policy|February 24, 2001
Priority-setting in New Zealand: translating principles into practiceT Ashton, J Cumming, N Devlin
The New Zealand Medical Journal|December 10, 1999
Rationing health care: how should the HFA proceed?N Devlin, T Ashton, J Cumming
Current Opinion in Chemical Biology|May 24, 2011
Found in translation: applications of protein and peptide molecular diversityT Ashton Cropp, Dewey G McCafferty
Journal of Medicinal Chemistry|March 1, 1975
Synthesis and evaluation of 6-arylactamido-2,4-diaminoquinazolines and related compounds as folic acid antagonistsJ B Hynes, W T Ashton
Pageof 17

Showing results (31-40 of 169) with videos related to

Sort By:
Pageof 17
Journal of Microscopy|July 1, 1981
The myosin filament. VIII. Preservation of subfilament organizationF T Ashton, F A Pepe
European Journal of Biochemistry|April 12, 2001
The oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albuminP Finotti, A Pagetta, T Ashton
Journal of Medicinal Chemistry|March 1, 1973
Irreversible enzyme inhibitors. 197. Water-soluble reversible inhibitors of dihydrofolate reductase with potent antitumor activity derived from 4, 6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazineB R Baker, W T Ashton
Nature Chemistry|March 26, 2024
Blocking and rescuing tryptophan interactionsAidan K Haney, T Ashton Cropp
British Journal of Addiction|July 1, 1989
Alcohol taxes: do the poor pay more than the rich?T Ashton, S Casswell, L Gilmore
Journal of Medicinal Chemistry|September 1, 1974
Quinazolines as inhibitors of dihydrofolate reductase. 2J B Hynes, W T Ashton
Journal of Health Services Research & Policy|February 24, 2001
Priority-setting in New Zealand: translating principles into practiceT Ashton, J Cumming, N Devlin
The New Zealand Medical Journal|December 10, 1999
Rationing health care: how should the HFA proceed?N Devlin, T Ashton, J Cumming
Current Opinion in Chemical Biology|May 24, 2011
Found in translation: applications of protein and peptide molecular diversityT Ashton Cropp, Dewey G McCafferty
Journal of Medicinal Chemistry|March 1, 1975
Synthesis and evaluation of 6-arylactamido-2,4-diaminoquinazolines and related compounds as folic acid antagonistsJ B Hynes, W T Ashton
Pageof 17